Russian institute completes Human clinical trial
- The COVID-19 vaccine developed by Russia’s Gamalei Institute of Epidemiology and Microbiology has successfully completed the Human Clinical Trials.
- The main objective of the Human Clinical Trials was to study the outcomes for the safety of human health after the vaccine is administered; this has been successfully done during the trials.
.PNG)
